ArticleCureus2025
Dreaded Degos Disease in Childhood.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Degos disease or malignant atrophic papulosis is a rare multisystem vascular disease of unknown etiology most commonly affecting the small- to medium-sized arteries of the dermis of the skin, gastrointestinal tract, and central nervous system. Endothelial cell damage and the activation of the coagulation cascade leading to the obliterative thrombosis of the vessel wall are the main pathogenic mechanisms behind the disease. The characteristic cutaneous features are porcelain white atrophic papules with a peripheral rim of erythema seen commonly over the trunk, chest, and upper and lower limbs. In Degos disease, cutaneous and systemic manifestations typically do not present simultaneously, with skin lesions often appearing first. Systemic involvement, affecting organs such as the gastrointestinal tract or central nervous system, may develop months or years later. Patients should be closely monitored for potential systemic complications, as these significantly impact prognosis, necessitating multidisciplinary care to ensure early detection and management. The disease carries a poor prognosis because of systemic involvement. Degos disease is extremely rare in children with very few cases being reported in literature. We hereby report a rare case of Degos disease in a five-year-old female child with lesions confined to the skin with a lack of systemic involvement.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.